In the News

Update: J&J Hit With $80M Punitive Damages Verdict In NJ Talc Case

AbbVie Ordered To Pay $3M In AndroGel Retrial

An Illinois federal jury found AbbVie Inc.'s AndroGel product caused an Oregon man's heart attack and ordered the company to pay him more than $3 million.

Teva Exits Philly Reglan Mass Tort With Settlement

Teva settlement affects roughly 1,700 cases pending in the Reglan mass tort program in the Philadelphia.

4th Circ. Upholds $18.5M Boston Scientific Mesh Verdict

Fourth Circuit rejected Boston Scientific's appeal of an $18.5 million verdict in a trial over injuries allegedly caused by its pelvic mesh devices.

Auxilium Settles 1st Philly Testosterone Case

Auxilium Pharmaceuticals Inc. avoids an trial over the alleged connection between its testosterone gel and a user's stroke.

Johnson & Johnson Ethicon Unit Hit With $15M Pelvic Mesh Verdict In NJ

After a three week trial, NJ jury hands down $15M verdict in favor of plaintiff over claims J&J lied about the safety of pelvic mesh product.

Johnson & Johnson Hit with $247 Million Verdict in Hip Implant Trial

A federal jury in Dallas ordered Johnson & Johnson to pay $247 million to six patients who were injured by defective Pinnacle hip implants.

Congress Allied with Drug Company Lobbyists to Derail the DEA’s War on Opioids

Amid a targeted lobbying effort, Congress weakened the DEA’s ability to go after drug distributors, even as opioid-related deaths continue to rise.

FDA Safety Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants

New FDA safety information shows the complications of treating addicted individuals.

Nearly Half Of Patients Who Stop Taking Opioids For Six Months Resume Use Later

According to researchers at Magellan Health in Scottsdale, over 50 percent of patients who quit opioids for six months will resume use sometime thereafter.